November 25, 2015
Recommended Topic Related To:


"The 70,000 diagnostic codes known as ICD-10 made their long and nervously awaited debut in medical practices today.

Claims for any service performed on October 1 and beyond must bear one or more of the new diagnostic codes ” more nume"...




Aside from possible ovarian hyperstimulation (see WARNINGS), little is known concerning the consequences of acute overdosage with menotropins.


Repronex® (menotropins for injection) is contraindicated in women who have:

  1. A high FSH level indicating primary ovarian failure.
  2. Uncontrolled thyroid and adrenal dysfunction.
  3. An organic intracranial lesion such as a pituitary tumor.
  4. The presence of any cause of infertility other than anovulation unless they are candidates for in vitro-fertilization.
  5. Abnormal bleeding of undetermined origin.
  6. Ovarian cysts or enlargement not due to polycystic ovary syndrome.
  7. Prior hypersensitivity to menotropins.
  8. Repronex® (menotropins for injection) is not indicated in women who are pregnant. There are limited human data on the effects of menotropins when administered during pregnancy.
This monograph has been modified to include the generic and brand name in many instances.

Last reviewed on RxList: 10/9/2008


Repronex - User Reviews

Repronex User Reviews

Now you can gain knowledge and insight about a drug treatment with Patient Discussions.

Here is a collection of user reviews for the medication Repronex sorted by most helpful. Patient Discussions FAQs

Report Problems to the Food and Drug Administration


You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Women's Health

Find out what women really need.